Sarah Cannon Research Institute at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Sarah Cannon Research Institute brings 6 presentations to ASH 2026 in New Orleans, and exhibits at Booth 2316. Sarah Cannon Research Institute brings early-phase lymphoma and cancer trial results alongside community practice sessions. Work includes first-in-human studies of an mRNA therapy and a ROR1-targeted antibody-drug conjugate.
| Organization | ASH 2026 Attendance |
|---|---|
Sarah Cannon Research Institute Nashville, TN | |
Oncology research organization running cancer clinical trials in community settings for more than 30 years. | Booth Exhibiting at Booth 2316 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 11:00am–2:00pm Best Practice Use of Bispecific Antibodies in Non-Hodgkin Lymphoma – A Second Opinion Case Review Difficult non-Hodgkin lymphoma cases treated or considered for bispecific antibodies, with reviews of recent data, current practice, and ongoing trials. Session Fri Dec 11 2:15pm–2:35pm Oral Sat Dec 12 2:00pm–3:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Session |
Find decision makers at Sarah Cannon Research Institute
Tell us what you sell and we’ll find the people at Sarah Cannon Research Institute most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction